CSG Stock: One Man's €1.4 Billion Claim Is Haunting a Defense Giant
10.06.2026 - 12:45:03 | boerse-global.de
The Czechoslovak Group (CSG) boasts a €17 billion order backlog, an 83% leap in net profit, and unanimous buy ratings from all ten analysts covering the stock. Yet its shares trade at 14.59 euros—more than 60% below the January all-time high of 36.05 euros. The culprit isn't weak operations; it's a bitter governance dispute that has investors looking past the balance sheet.
Petr KratochvĂl, a minority shareholder holding roughly 10% of CSG Land Systems CZ and 9% of the MSM Group, is demanding 1.4 billion euros for his stakes. CSG's counteroffer is barely a tenth of that. The resulting gap—about 31 billion Czech korunas—has frozen negotiations and dragged courts in both the Czech Republic and Slovakia into the fray. KratochvĂl was ousted as chairman in March over an alleged conflict of interest, and he has since challenged both the valuation of his holdings and internal share transfers. For investors, this legal uncertainty acts as a poison pill that no amount of operational strength can neutralize.
That operational strength, however, is considerable. First-quarter revenue hit 1.544 billion euros, while operating EBIT rose 8.7% to 372 million euros. The order book expanded 15.1% to 17 billion euros, with a further 27 billion euros in the pipeline. Net profit surged 83%, and the operating margin landed squarely in the targeted 24-25% range. Management confirmed its full-year revenue guidance of 7.4 to 7.6 billion euros. Analysts are baffled: the median price target stands at 32.05 euros—more than double the current share price. Even Berenberg, which trimmed estimates after mixed segment results, maintained its buy rating.
Should investors sell immediately? Or is it worth buying CSG?
Meanwhile, CSG is quietly tightening its grip on the ammunition supply chain. Early June brought two contracts for mechanical and electronic fuzes for large-calibre munitions, valued in the high double-digit millions, with deliveries to European NATO customers starting this year. The electronic fuzes will be produced through Fuchs Electronics Europe, a newly formed joint venture with South Africa's Reunert based in Slovakia. Days earlier, CSG disclosed that its subsidiary STALUNA TRADE holds nearly 10% of voting rights in Alzchem Group, a producer of nitroguanidine—a key ingredient for propellants and ammunition. And on June 1, a licensing deal with Ukrainian Armor kicked off production of NATO-standard artillery shells in Ukraine: initially 100,000 rounds in 155 mm calibre and 50,000 in 105 mm per year, with a target of 850,000 heavy-calibre shells annually by end-2026, up from 550,000 in 2025.
Against this backdrop, the company's PR push at the Euronext IPO Day in Prague this week felt more like scene-setting than substance. CSG managers Zden?k Jurák and Petr Formánek took the stage to discuss their Amsterdam listing experience, but no fresh business figures or major orders were announced. The event was pure investor relations—an effort to raise the group's capital markets visibility. Yet with the stock down 8% in the past month alone and trading well below its 200-day moving average of 18.97 euros, goodwill alone won't reverse the trend.
Technical signals are screaming oversold. The relative strength index sits at 29, even deeper than the 31.5 reading from earlier in the week, and the share price is more than 24% below its 50-day average. But in the current environment, that has not been enough to lure buyers. The market is pricing in legal risk, not earnings momentum.
What could break the deadlock? First-instance court rulings from Prague or Bratislava could reshape the landscape overnight—for better or worse. The next scheduled catalyst is the half-year report on August 7, 2026 (note: likely 2025, but as reported), with a silent period beginning July 8. Until then, CSG’s stock looks trapped between a stellar operational story and a governance fight that no spreadsheet can solve.
Ad
CSG Stock: New Analysis - 10 June
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
